Replimune Correlations

REPL Stock  USD 13.24  0.25  1.85%   
The current 90-days correlation between Replimune Group and Kura Oncology is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Replimune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Replimune Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Replimune Correlation With Market

Modest diversification

The correlation between Replimune Group and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving together with Replimune Stock

  0.64FENC Fennec PharmaceuticalsPairCorr

Moving against Replimune Stock

  0.64NAMSW NewAmsterdam Pharma Upward RallyPairCorr
  0.38INZY Inozyme PharmaPairCorr
  0.37ILMN IlluminaPairCorr
  0.54PTITF PT Indosat TbkPairCorr
  0.4ADUS Addus HomeCarePairCorr
  0.38TLKMF Telkom Indonesia TbkPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GOSSNVCT
PTGXNUVL
KURANUVL
PTGXKURA
PTGXVTYX
GOSSASND
  
High negative correlations   
NVCTVTYX
KURAKRON
GOSSVTYX
PTGXGOSS
PTGXNVCT
GOSSNUVL

Risk-Adjusted Indicators

There is a big difference between Replimune Stock performing well and Replimune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Replimune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NUVL  1.86 (0.14) 0.00  1.36  0.00 
 3.54 
 11.10 
VTYX  4.52 (0.05) 0.00 (0.05) 0.00 
 11.35 
 35.02 
ASND  2.21  0.36  0.17  0.42  1.88 
 5.85 
 14.35 
UTHR  1.15  0.00  0.00 (0.04) 1.72 
 2.26 
 8.88 
NVCT  3.31  0.70  0.18 (0.65) 3.46 
 7.96 
 25.78 
LYRA  3.25  0.36  0.05 (0.42) 3.39 
 5.88 
 27.65 
KRON  2.17  0.25  0.10  1.15  1.94 
 5.15 
 17.56 
GOSS  4.24  1.00  0.20  1.74  4.12 
 8.70 
 36.67 
KURA  2.66 (0.91) 0.00 (3.30) 0.00 
 4.45 
 36.77 
PTGX  2.27 (0.19) 0.00 (0.15) 0.00 
 3.48 
 18.65 

Replimune Corporate Management

Colin LoveChief OfficerProfile
Christopher SarchiChief OfficerProfile
Pamela EspositoChief Business OfficerProfile
Paul BullockChief HeadProfile
MBA MAChief OfficerProfile
Andrew SchwendenmanChief TreasurerProfile